Publications by authors named "J Lyo"

Distinguishing treatment-induced imaging changes from progressive disease has important implications for avoiding inappropriate discontinuation of a treatment. Our goal in this study is to evaluate the utility of dynamic contrast-enhanced (DCE) perfusion MRI as a biomarker for the early detection of progression. We hypothesize that DCE-MRI may have the potential as an early predictor for the progression of disease in GBM patients when compared to the current standard of conventional MRI.

View Article and Find Full Text PDF
Article Synopsis
  • Dynamic contrast-enhanced MRI (DCE-MRI) is being used to study vertebral body tumors, but the delayed contrast flow in the spine can lead to incorrect diagnoses of malignancies due to miscalculations in analyses.
  • Researchers adjusted the arterial input function (AIF) curve to compensate for this delay, hypothesizing that this would improve the accuracy of blood volume measurements (V) in vertebral lesions.
  • In a study of 18 patients with confirmed spinal metastases, adjustments to the AIF curve resulted in significantly higher V values, indicating that refining the DCE-MRI analysis can enhance the detection of active metastases.
View Article and Find Full Text PDF

Background Artificial intelligence (AI) applications for cancer imaging conceptually begin with automated tumor detection, which can provide the foundation for downstream AI tasks. However, supervised training requires many image annotations, and performing dedicated post hoc image labeling is burdensome and costly. Purpose To investigate whether clinically generated image annotations can be data mined from the picture archiving and communication system (PACS), automatically curated, and used for semisupervised training of a brain MRI tumor detection model.

View Article and Find Full Text PDF

Purpose: Although exon 14 (ex14)-altered lung cancers were first identified more than a decade and a half ago, the frequency of CNS metastatic disease remains poorly defined. Furthermore, the seminal trial of crizotinib in these patients (PROFILE 1001) did not report patterns of CNS response or progression.

Patients And Methods: Patients with pathologically confirmed, advanced non-small-cell lung cancers (NSCLC) harboring a ex14 alteration by targeted DNA/RNA sequencing were studied.

View Article and Find Full Text PDF

Background Dynamic contrast agent-enhanced (DCE) perfusion MRI may help differentiate between nonneoplastic and malignant lesions in the spine. Purpose To investigate the correlation between fractional plasma volume (), a parameter derived from DCE perfusion MRI, and histopathologic diagnosis for spinal lesions. Materials and Methods In this retrospective study, patients who underwent DCE perfusion MRI and lesion biopsy between May 2015 and May 2018 were included.

View Article and Find Full Text PDF